RegCell
Regulatory T-cell therapies to restore immune tolerance in autoimmune disease
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
RegCell is a biotechnology company developing regulatory T-cell (Treg) therapies for autoimmune diseases and transplantation. Its platform epigenetically reprograms T cells based on discoveries by scientific founder Dr. Shimon Sakaguchi. Headquartered in Emeryville, California, with roots and R&D ties in Japan, RegCell is advancing toward clinical development for autoimmune indications. CEO Michael McCullar, PhD.
- Website
- regcellbio.com
- Stage
- series-a
- Location
- Emeryville, CA, USA
- Added via
- web
- Ownership
- unclaimed